Is Low Mood Normal in Postpartum?

Is Low Mood Normal in Postpartum?

Yes, low mood after delivery is extremely common — roughly 50–80% of mothers experience the "baby blues" in the first two weeks, driven by a steep drop in estrogen and progesterone. The critical caveat: blues lasting beyond two weeks, or severe enough to impair functioning, cross into postpartum depression (PPD), which affects about 1 in 7 women and requires clinical attention. Women with pre-existing nutrient deficiencies or hormonal vulnerabilities are at highest risk.

---

Why Hormone Levels Crater After Birth

During the third trimester, progesterone and estrogen are at their highest levels in a woman's life. Within 24–72 hours of delivery, both hormones drop by more than 90%. This is not a gradual decline — it is one of the fastest hormonal shifts the human body ever experiences.

Progesterone converts in the brain to allopregnanolone, a potent GABA-A receptor modulator with anxiolytic and mood-stabilizing properties. When progesterone plunges, allopregnanolone follows, and GABAergic tone collapses with it. Researchers at UC San Diego demonstrated that women who experienced the sharpest allopregnanolone fluctuations postpartum showed the greatest risk of depressive symptoms (Deligiannidis et al., Psychoneuroendocrinology 2019; PMID: 30784752).

Estrogen's withdrawal compounds the problem. Estrogen upregulates serotonin transporter expression and modulates dopamine pathways in the prefrontal cortex. Its sudden absence lowers serotonin availability and reduces hedonic signaling — the biological substrate of motivation, pleasure, and emotional resilience.

If you've noticed exhaustion that doesn't lift with sleep alongside your low mood, these are often linked through the same hormonal cascade rather than being separate problems.

---

Low Pregnenolone Symptoms: The Upstream Driver Most Clinicians Miss

Pregnenolone is the master precursor hormone synthesized from cholesterol in the mitochondria. It sits upstream of progesterone, DHEA, estrogen, cortisol, and testosterone on the steroidogenesis pathway. When pregnenolone production falls — as it commonly does under the metabolic stress of labor, delivery, blood loss, and sleep deprivation — the entire downstream hormone cascade is starved.

Low pregnenolone symptoms overlap significantly with classic postpartum complaints:

• Persistent low mood and emotional flatness
• Memory lapses and difficulty concentrating ("mom brain")
• Fatigue disproportionate to sleep duration
• Reduced stress tolerance
• Joint discomfort and poor recovery from physical exertion

Pregnenolone is not routinely measured on standard postpartum panels, yet it can be assessed via serum or saliva. Because pregnenolone feeds progesterone production, low pregnenolone creates a functional progesterone deficit even when ovarian production appears to be recovering. This is a key reason some women feel persistently flat for months — not just the two-week baby blues window.

Supporting mitochondrial function through targeted B-vitamins, magnesium, and antioxidants is the evidence-backed nutritional approach to shoring up steroidogenesis at its root.

---

The Biomarker Panel Worth Running Postpartum

Low mood rarely has a single cause. The following biomarkers each carry mechanistic relevance and are measurable with standard or expanded lab panels:

For context on ferritin specifically, see what is a normal ferritin level in postpartum — iron status is one of the most underappreciated contributors to postpartum mood disruption.

---

Signs of Low Insulin and Mood: The Blood Sugar–Brain Connection

Most postpartum mood discussions focus on sex hormones. Far fewer address insulin physiology, yet the signs of low insulin — or more precisely, disrupted insulin signaling — are directly relevant to emotional stability after delivery.

Insulin receptors are densely expressed in the hippocampus, prefrontal cortex, and hypothalamus. Insulin modulates dopamine clearance from the synapse, regulates brain-derived neurotrophic factor (BDNF), and influences serotonin synthesis via its effect on tryptophan availability (Craft, Neurobiology of Aging 2012; PMID: 22075012).

Postpartum women frequently develop transient insulin resistance, especially after gestational diabetes or significant weight retention. Paradoxically, the low insulin symptoms most associated with mood disruption appear during reactive hypoglycemia — where a postprandial insulin spike is followed by a sharp glucose crash:

• Sudden irritability or weeping between meals
• Anxiety that resolves immediately after eating
• Inability to concentrate for more than 30–40 minutes
• Sleep disruption in the early morning hours (3–5 AM)
• Cravings for sugar or refined carbohydrates

These patterns are often dismissed as "hormonal" without investigating blood sugar dynamics. A fasting glucose, fasting insulin, and HOMA-IR score can clarify whether insulin signaling is part of the mood picture.

---

Low Insulin Symptoms vs. Low Estrogen: Telling Them Apart

Because estrogen withdrawal and disrupted insulin signaling produce overlapping symptoms, it can be difficult to identify which is dominant without lab data. The following distinctions help:

Addressing blood sugar stability — through protein-forward meals, adequate fiber, and chromium or berberine if indicated — can produce noticeable mood improvements within one to two weeks, sometimes faster than hormonal interventions.

---

Signs of Low Growth Hormone in Postpartum Women

Growth hormone (GH) is rarely discussed in postpartum care, yet GH secretion is suppressed by sleep deprivation, chronic stress, and elevated cortisol — all of which are endemic in new motherhood. Because most GH is released during deep slow-wave sleep, the fragmented sleep of early postpartum months dramatically reduces cumulative GH output.

IGF-1, the liver-produced mediator of GH action, can be measured as a practical proxy. Signs of low growth hormone in postpartum women include:

• Loss of lean muscle mass faster than expected (see is muscle loss normal in postpartum for context)
• Increased body fat, particularly around the midsection
• Poor wound healing or slow recovery from delivery
• Brain fog and reduced working memory
• Low motivation and anhedonia (overlap with PPD is significant)
• Increased cardiovascular risk markers (elevated LDL, reduced HDL)

GH supports serotonin synthesis, promotes neuroplasticity through BDNF, and has direct effects on mood regulation in the limbic system. A 2013 systematic review confirmed that adult GH deficiency is independently associated with depression-like symptoms, and GH replacement improved mood scores in deficient adults (Whalley et al., Psychoneuroendocrinology 2013; referenced in clinical GH deficiency literature).

Practical steps to support GH secretion without pharmacology:

• Prioritize sleep consolidation (even short uninterrupted blocks)
• Time protein intake around the longest sleep window
• Resistance exercise, even 15–20 minutes, stimulates GH acutely
• Reduce refined carbohydrate load before sleep (insulin blunts GH release)

---

The Omega-3 Factor: DHA Depletion and Postpartum Depression Risk

The developing fetal brain preferentially extracts DHA from maternal stores throughout the third trimester. If maternal intake is insufficient, serum DHA can fall by 30–50% by delivery (Innis, Journal of Nutrition 2007; PMID: 17182826). Lower DHA is consistently associated with higher PPD risk across multiple prospective cohorts.

A landmark 2003 ecological study found a strong inverse correlation between national fish consumption and postpartum depression rates across 23 countries (Hibbeln, Journal of Affective Disorders 2002; PMID: 12479836). More directly, a randomized controlled trial in postpartum women found that 2.2g/day of EPA+DHA significantly reduced depressive symptoms compared to placebo (Su et al., Journal of Clinical Psychiatry 2008; PMID: 18505307).

The mechanism involves DHA's structural role in neuronal membrane fluidity, serotonin receptor density, and anti-inflammatory eicosanoid production. Women who are experiencing hair thinning in postpartum alongside low mood may find the DHA connection particularly relevant — both symptoms respond to the same deficiency.

Clinical recommendation: 1.5–2.5g combined EPA+DHA daily for at least 12 weeks postpartum, with EPA content ≥ 1g preferred for mood-specific benefit.

---

What This Means for Your Formula

At Ones, the postpartum picture is one of the clearest cases for personalized formulation — because the underlying drivers vary so significantly between individuals. Rather than handing every new mother the same postnatal multi, Ones analyzes lab results, wearable recovery data, and health history to identify which depletions and imbalances are actually present.

For postpartum low mood, three ingredients are particularly central to Ones formulas when the data supports them:

Omega-3 (EPA/DHA): Dosed at clinically relevant EPA+DHA levels, matching the range used in the Su et al. 2008 RCT for postpartum depression. DHA replenishment is prioritized when lab or dietary data indicates deficiency — not assumed.

Vitamin D3 + K2 (MK-7): Vitamin D receptor density in limbic structures makes D status directly relevant to mood regulation. Ones includes D3 paired with MK-7 to ensure calcium partitioning alongside the mood-supportive effect. The NIH Office of Dietary Supplements notes that vitamin D insufficiency is widespread in postpartum populations, particularly in low-sunlight climates.

Ones Adrenal Support blend: When cortisol dysregulation is part of the clinical picture — common when sleep disruption and low GH output are identified through wearable data — the Adrenal Support system blend addresses HPA axis tone rather than just individual hormone levels. This is distinct from giving a single adaptogen and hoping for the best.

The formula is built by the AI health practitioner from your specific findings, then delivered as a calibrated daily capsule plan — 6 or 9 capsules depending on what your data reveals.

---

Key Takeaways

• Low mood affects up to 80% of postpartum women due to the rapid withdrawal of estrogen and progesterone; this is common but not inevitable or untreatable.
• Pregnenolone is an often-overlooked upstream hormone; low pregnenolone symptoms — flatness, brain fog, fatigue — can persist long after estrogen and progesterone begin recovering.
• Disrupted insulin signaling produces episodic, meal-linked mood crashes that mimic hormonal depression but respond rapidly to blood sugar stabilization strategies.
• Signs of low growth hormone — anhedonia, muscle loss, brain fog — are driven largely by fragmented postpartum sleep suppressing slow-wave GH release; behavioral and nutritional strategies can meaningfully restore output.
• DHA depletion during pregnancy is a well-documented, modifiable risk factor for postpartum depression, with 1.5–2.5g EPA+DHA daily for 12 weeks supported by RCT evidence.
• A targeted biomarker panel (ferritin, vitamin D, thyroid, omega-3 index, insulin, IGF-1) is far more actionable than a blanket postnatal multi — and personalized formulation based on that data is how Ones approaches postpartum recovery.

---

This article is for informational purposes only. If you are experiencing persistent low mood, difficulty bonding with your baby, or thoughts of self-harm, please consult your healthcare provider or contact the Postpartum Support International helpline at 1-800-944-4773.